Page 378 - Read Online

Reverberi et al. Mini-invasive Surg 2020;4:43 I http://dx.doi.org/10.20517/2574-1225.2020.33 Page 9 of 10

7. Ball D, Mai GT, Vinod S, Babington S, Ruben J, et al. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-
small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol 2019;20:494-503.
8. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-
small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2:S94-100.
9. Bradley JD, El Naqa I, Drzymala RE, Trovo M, Jones G, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung
cancer: the pattern of failure is distant. Int J Radiat Oncol Biol Phys 2010;77:1146-50.
10. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, et al. Excessive toxicity when treating central tumors in a phase ii study
of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-9.
11. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, et al. Stereotactic body radiation therapy for inoperable early stage lung
cancer. JAMA 2010;303:1070-6.
12. Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, et al. Stereotactic body radiation therapy for operable early-stage lung
cancer: findings from the NRG oncology RTOG 0618 trial. JAMA Oncol 2018;4:1263-6
13. Eriguchi T, Takeda A, Sanuki N, Tsurugai Y, Aoki Y, et al. Stereotactic body radiotherapy for operable early-stage non-small cell lung
cancer. Lung Cancer 2017;109:62-7.
14. Guckenberger M, Andratschke N, Dieckmann K, Hoogeman MS, Hoyer M, et al. ESTRO ACROP consensus guideline on
implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother
Oncol 2017;124:11-7.
15. Videtic GM, Hu C, Singh AK, Chang JY, Parker W, et al. A randomized phase 2 study comparing 2 stereotactic body radiation therapy
schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG
N0927). Int J Radiat Oncol Biol Phys 2015;93:757-64.
16. Singh AK, Gomez-Suescun JA, Stephans KL, Bogart JA, Hermann GM, et al. One versus three fractions of stereotactic body radiation
therapy for peripheral stage I to II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial. Int J Radiat Oncol Biol Phys
2019;105:752-9.
17. Ma SJ, Cummings M, Serra LM, Syed YA, Hermann GM, et al. Three- versus five-fraction regimens of stereotactic body radiotherapy for
peripheral early-stage non-small-cell lung cancer: a two-institution propensity score-matched analysis. Clin Lung Cancer 2018;19:e297-
302.
18. Cummings MA, Ma SJ, Hermann G, Serra L, Syed Y, et al. Comparison of single- and five-fraction regimens of stereotactic body
radiation therapy for peripheral early-stage non-small-cell lung cancer: a two-institution propensity-matched analysis. Clin Lung Cancer
2018;19:511-7.
19. Stephans KL, Woody NM, Reddy CA, Varley M, Magnelli A, et al. Tumor control and toxicity for common stereotactic body radiation
therapy dose-fractionation regimens in stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2018;100:462-9.
20. Roach MC, Robinson CG, DeWees TA, Ganachaud J, Przybysz D, et al. Stereotactic body radiation therapy for central early-stage
NSCLC: results of a prospective phase I/II trial. J Thorac Oncol 2018;13:1727-32.
21. Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, et al. Safety and efficacy of a five-fraction stereotactic body radiotherapy
schedule for centrally located non-small-cell lung cancer: NRG Oncology/RTOG 0813 Trial. J Clin Oncol 2019;37:1316-25.
22. Tekatli H, Haasbeek N, Dahele M, De Haan P, Verbakel W, et al. Outcomes of hypofractionated high-dose radiotherapy in poor-risk
patients with “Ultracentral” non-small cell lung cancer. J Thorac Oncol 2016;11:1081-9.
23. Zhao Y, Khawandanh E, Thomas S, Zhang S, Dunne EM, et al. Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when
prioritizing organs at risk for central and ultracentral lung tumors. Radiat Oncol 2020;15:50.
24. Dalwadi SM, Szeja SS, Bernicker EH, Butler EB, Teh BS, et al. Practice patterns and outcomes in elderly stage I non-small-cell lung
cancer: a 2004 to 2012 SEER analysis. Clin Lung Cancer 2018;19:e269-76.
25. Brooks ED, Sun B, Zhao L, Komaki R, Liao Z, et al. Stereotactic ablative radiation therapy is highly safe and effective for elderly patients
with early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2017;98:900-7.
26. Kreinbrink P, Blumenfeld P, Tolekidis G, Sen N, Sher D, et al. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small
cell lung cancer in the very elderly (≥80years old): extremely safe and effective. J Geriatr Oncol 2017;8:351-5.
27. Cassidy RJ, Patel PR, Zhang X, Press RH, Switchenko JM, et al. Stereotactic body radiotherapy for early-stage non-small-cell lung
cancer in patients 80 years and older: a multi-center analysis. Clin Lung Cancer 2017;18:551-8.e6.
28. Videtic GMM, Woody NM, Reddy CA, Stephans KL. Never too old: a single-institution experience of stereotactic body radiation therapy
for patients 90 years and older with early stage lung cancer. Pract Radiat Oncol 2017;7:e543-9.
29. Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-
small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015;16:630-7.
30. Guckenberger M, Aerts JG, Van Schil P, Weder W. The American Society of Clinical Oncology-endorsed American Society for Radiation
Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: an expert opinion. J
Thorac Cardiovasc Surg 2019;157:358-61.
31. Whitson BA, Groth SS, Duval SJ, Swanson SJ, Maddaus MA. Surgery for early-stage non-small cell lung cancer: a systematic review of
the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. Ann Thorac Surg 2008;86:2008-16; discussion
2016-8.
32. Zhang B, Zhu F, Ma X, Tian Y, Cao D, et al. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the
treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis. Radiother Oncol 2014;112:250-5.
33. Wang SW, Wang XX, Zhou Q, Xu YT, Xia WJ, et al. Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung